Zurich again crowned as the world’s smartest city
Lausanne/Singapore - For the fifth year in a row, Zurich has secured top spot in the global IMD Smart City Index. On the basis of numerous criteria, the index measures how smart a population perceives its city to be. In total, 142 cities were evaluated, with Geneva claiming fourth place and Lausanne securing seventh position.
Empa researchers develop cellulose-based aerogel
Dübendorf - A laboratory at the Swiss Federal Laboratories for Materials Science and Technology (Empa) has developed an ultralight, biodegradable and printable aerogel made from cellulose. This could be used for insulation in microelectronics, to slowly release medication in the body or as an implant.
Biognosys and Alamar seeking breakthrough in plasma biology
Schlieren/Fremont - Biognosys and Alamar Biosciences are joining forces to carry out joint research projects in the future. The two companies will combine their respective expertise in the area of proteomics in order to enable diseases to be detected at the earliest possible stage and to pave the way towards a breakthrough in plasma biology.
Information from the Board of Directors of the Greater Zurich Area
This message is only available in German
Drones navigate even dense forest
Birmensdorf/Zurich - Researchers at the Swiss Federal Institute for Forest, Snow and Landscape Research (WSL) and the Swiss Federal Institute of Technology Zurich have developed an innovative drone for biodiversity identification in forests. It can even weave its way through branches.
Legartis and Implenia automate contract reviews in the construction industry
Zurich/Opfikon - Legartis and Implenia are aiming to shorten the amount of time spent reviewing comprehensive contracts in the construction industry. Legartis, which specializes in using artificial intelligence (AI) for contract review, and international construction company Implenia are developing an AI module for this purpose.
Galderma completes largest IPO on a global level in Q1
Zurich/Zug - Galderma has banked nearly 2.3 billion Swiss francs following its listing on the SIX Swiss Exchange. The pharma firm was therefore responsible for the largest IPO in the world in the first quarter of 2024. The global issuance volume came in at 23.7 billion US dollars overall.
Questel integrates ipQuants' patent co-pilot
Schaffhausen/Paris - ipQuants' software to support the patent process is becoming accessible worldwide through a strategic alliance. Questel, a Paris-based company specialising in intellectual property management, is incorporating ipQuants' patent co-pilot Qthena into its global platform.
Ypsomed invests over 100 million francs in Solothurn
Solothurn/Burgdorf - Ypsomed is to invest 100 million Swiss francs in expanding production capacities for autoinjectors at its Solothurn site. In future, the company plans to focus fully on its insulin pumps and is selling its pen needle and blood glucose monitoring systems businesses to Italy.
Meet with an expansion expert
Our services are free of charge and include:
- Introduction to key contacts in industry, academia, and government
- Advice on regulatory framework, taxes, labor, market, and setting up a company
- Custom-made fact-finding visits, including office and co-working space